CCR2 antagonist

This page covers all CCR2 antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CCR2 (C-C chemokine receptor type 2), CCR2.

Targets

CCR2 (C-C chemokine receptor type 2) · CCR2

Phase 3 pipeline (2)

• ABT-267 · AbbVie (prior sponsor, Abbott) · Immunology / Inflammation
  ABT-267 is a selective inhibitor of the chemokine receptor CCR2 that reduces monocyte recruitment to sites of inflammation.
• SR34006 · Sanofi · Immunology
  SR34006 is a selective antagonist of the chemokine receptor CCR2, which blocks the recruitment of monocytes and inflammatory cells to sites of inflammation.

Phase 2 pipeline (1)

• ABT-530 · AbbVie · Immunology
  ABT-530 is a selective inhibitor of the chemokine receptor CCR2 that reduces inflammatory monocyte recruitment to sites of inflammation.